THC(THC)
THC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $21.98B | $22.33B | $23.52B | $24.08B |
| Low | $21.86B | $22.05B | $23.52B | $23.78B |
| High | $22.35B | $22.69B | $23.53B | $24.52B |
| EBITDA Avg | $6.94B | $7.05B | $7.43B | $7.60B |
| Low | $6.90B | $6.96B | $7.43B | $7.51B |
| High | $7.06B | $7.17B | $7.43B | $7.74B |
| EBIT Avg | $6.16B | $6.26B | $6.59B | $6.75B |
| Low | $6.13B | $6.18B | $6.59B | $6.66B |
| High | $6.26B | $6.36B | $6.59B | $6.87B |
| Net Income Avg | $1.64B | $1.63B | $1.79B | $2.07B |
| Low | $1.56B | $1.39B | $1.42B | $2.03B |
| High | $1.73B | $1.87B | $2.16B | $2.11B |
| EPS Avg | $17.94 | $17.73 | $19.92 | $22.74 |
| Low | $17.14 | $15.28 | $15.59 | $22.37 |
| High | $19.00 | $20.58 | $23.81 | $23.28 |
| Analysts (Rev / EPS) | 15 / 12 | 15 / 12 | 9 / 4 | 4 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.46B | $5.72B | $5.44B | $5.50B | $5.53B | $5.79B | $5.66B | $5.73B |
| Low | $5.43B | $5.65B | $5.38B | $5.44B | $5.47B | $5.72B | $5.60B | $5.67B |
| High | $5.49B | $5.77B | $5.50B | $5.55B | $5.58B | $5.84B | $5.72B | $5.79B |
| EBITDA Avg | $1.72B | $1.80B | $1.72B | $1.74B | $1.75B | $1.83B | $1.79B | $1.81B |
| Low | $1.71B | $1.79B | $1.70B | $1.72B | $1.73B | $1.81B | $1.77B | $1.79B |
| High | $1.73B | $1.82B | $1.74B | $1.75B | $1.76B | $1.85B | $1.81B | $1.83B |
| EBIT Avg | $1.53B | $1.60B | $1.52B | $1.54B | $1.55B | $1.62B | $1.59B | $1.61B |
| Low | $1.52B | $1.58B | $1.51B | $1.52B | $1.53B | $1.60B | $1.57B | $1.59B |
| High | $1.54B | $1.62B | $1.54B | $1.56B | $1.56B | $1.64B | $1.60B | $1.62B |
| Net Income Avg | $360M | $418M | $394M | $377M | $373M | $431M | $407M | $392M |
| Low | $336M | $412M | $389M | $372M | $368M | $425M | $401M | $386M |
| High | $394M | $424M | $399M | $382M | $378M | $437M | $412M | $397M |
| EPS Avg | $4.11 | $4.77 | $4.50 | $4.30 | $4.26 | $4.92 | $4.65 | $4.47 |
| Low | $3.83 | $4.71 | $4.44 | $4.24 | $4.20 | $4.85 | $4.58 | $4.41 |
| High | $4.50 | $4.84 | $4.56 | $4.36 | $4.31 | $4.98 | $4.71 | $4.53 |
| Analysts (Rev / EPS) | 11 / 12 | 5 / 10 | 5 / 5 | 6 / 5 | 9 / 5 | 5 / 5 | 4 / 7 | 6 / 6 |